Phase II trial of 177Lutetium radiolabeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 (177Lu-J591) in patients (pts) with metastatic androgen-independent prostate cancer (AIPC) Meeting Abstract
| Authors: | Bander, N. H.; Nanus, D. M.; Milowsky, M. I.; Morris, M. J.; Jeske, S.; Vallabhajosula, S.; Goldsmith, S. J. |
| Abstract Title: | Phase II trial of 177Lutetium radiolabeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 (177Lu-J591) in patients (pts) with metastatic androgen-independent prostate cancer (AIPC) |
| Meeting Title: | 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 25 |
| Issue: | 18 Suppl. |
| Meeting Dates: | 2007 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2007-06-19 |
| Start Page: | 651s |
| Language: | English |
| ACCESSION: | WOS:000455043704029 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2007.25.18_suppl.15523 |
| Notes: | Meeting Abstract: 15523 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work